Research progress on preclinical efficacy evaluation of COVID-19 complicated with cytokine storm / 中国药理学通报
Chinese Pharmacological Bulletin
; (12): 911-916, 2021.
Artigo
em Chinês
| WPRIM (Pacífico Ocidental)
| ID: wpr-1014458
Biblioteca responsável:
WPRO
ABSTRACT
Studies have shown that COVID-19 patients infected with SARS-CoV-2 have severe pulmonary inflammation and cytokine storm, so the treatment of cytokine storm is an important part of rescuing critically ill patients with COVID-19. As an important cause of death, the preclinical study of cytokine storm is essential, and related experiments in vivo and in vitro are also the only way to develop new drugs for COVID-19 in the future. This paper reviews the in vitro and in vivo experimental methods of cytokine storm research articles at home and abroad in recent years, including the establishment of animal models, cell evaluation methods, pharmacodynamic evaluation indicators, etc., in order to provide reference and guidance for the experimental design methods of cytokine storm.
Texto completo:
Disponível
Base de dados:
WPRIM (Pacífico Ocidental)
Idioma:
Chinês
Revista:
Chinese Pharmacological Bulletin
Ano de publicação:
2021
Tipo de documento:
Artigo